Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Crescita Therapeutics Inc.

Crescita Reports Third Quarter 2023 Results
From Crescita Therapeutics Inc.
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports First Quarter 2023 Results
From Crescita Therapeutics Inc.
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Q4 and Fiscal 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Third Quarter 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Second Quarter 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
Tickers CRRTF OTC TSX:CTX
Crescita Reports Q4 and Fiscal 2021 Results
From Crescita Therapeutics Inc.
Via Business Wire
Tickers OTC TSX:CTX
Crescita Acquires Minority Interest in The Best You®
From Crescita Therapeutics Inc.
Via Business Wire
Tickers OTC TSX:CTX
Crescita Therapeutics and STADA Enter 15-Country Exclusive Licensing Agreement for Pliaglis®
From Crescita Therapeutics Inc.
Via Business Wire
Tickers OTC TSX:CTX
Crescita Therapeutics Announces 9-Country Licensing Agreement with Croma Pharma for Pliaglis®
From Crescita Therapeutics Inc.
Via Business Wire
Tickers OTC TSX:CTX
Crescita Therapeutics to Present at the 2021 Bloom Burton & Co. Healthcare Investor Conference
From Crescita Therapeutics Inc.
Via Business Wire
Tickers OTC TSX:CTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.